Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+319K
-
Total reported value, excl. options
-
$73.4M
-
Value change
-
+$1.88M
-
Put/Call ratio
-
1.35
-
Number of buys
-
32
-
Number of sells
-
-33
-
Price
-
$5.48
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q1 2022
97 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q1 2022.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
of 74.9M outstanding shares and own 17.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.42M shares), NOMURA HOLDINGS INC (2.4M shares), VANGUARD GROUP INC (1.81M shares), Elliott Investment Management L.P. (1.55M shares), CREDIT SUISSE AG/ (753K shares), STATE STREET CORP (687K shares), GEODE CAPITAL MANAGEMENT, LLC (661K shares), Cresset Asset Management, LLC (330K shares), NORTHERN TRUST CORP (324K shares), and MORGAN STANLEY (220K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.